"{\n \"business_address\": \"100 ABBOTT PARK ROAD, D-322 AP6D, ABBOTT PARK, IL 60064-3500\", \n \"business_phone_no\": \"8479376100\", \n \"ceo\": \"Miles D. White\", \n \"cik\": \"0000001800\", \n \"company_url\": \"www.abbott.com\", \n \"employees\": 75000, \n \"entity_legal_form\": \"COMPANY LIMITED\", \n \"entity_status\": null, \n \"hq_address1\": null, \n \"hq_address2\": null, \n \"hq_address_city\": null, \n \"hq_address_postal_code\": null, \n \"hq_country\": \"United States of America\", \n \"hq_state\": \"Illinois\", \n \"inc_country\": \"United States of America\", \n \"inc_state\": \"Illinois\", \n \"industry_category\": \"Health Services\", \n \"industry_group\": \"Medical Appliances & Equipment\", \n \"latest_filing_date\": \"2017-08-02\", \n \"legal_name\": \"ABBOTT LABORATORIES\", \n \"lei\": \"HQD377W2YR662HK5JX27\", \n \"long_description\": \"Abbott Laboratories manufactures and sells health care products worldwide. The company's Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Meniere's disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; cardiovascular and metabolic products; and influenza vaccines, as well as to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments to automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and a suite of informatics tools and professional services. The company's Nutritional Products segment provides pediatric and adult nutritional products. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, including test strips, sensors, data management decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products. It serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.\", \n \"mailing_address\": null, \n \"name\": \"Abbott Laboratories\", \n \"sector\": \"Healthcare\", \n \"securities\": [\n  {\n   \"composite_figi\": \"BBG000B9ZXB4\", \n   \"composite_figi_ticker\": \"ABT:US\", \n   \"currency\": \"USD\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XNYS\", \n   \"figi\": \"BBG000B9ZXB4\", \n   \"figi_exch_cntry\": \"US\", \n   \"figi_ticker\": \"ABT:US\", \n   \"figi_uniqueid\": \"EQ0010000200001000\", \n   \"last_crsp_adj_date\": \"2017-10-12\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XNYS\", \n   \"primary_listing\": true, \n   \"security_name\": \"ABBOTT LABORATORIES\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5N9M6\", \n   \"stock_exchange\": \"NYSE\", \n   \"ticker\": \"ABT\"\n  }, \n  {\n   \"composite_figi\": \"BBG000BN5WF4\", \n   \"composite_figi_ticker\": \"ABT:SW\", \n   \"currency\": \"CHF\", \n   \"delisted_security\": true, \n   \"etf\": false, \n   \"exch_symbol\": \"^XSWX\", \n   \"figi\": \"BBG000BN5X26\", \n   \"figi_exch_cntry\": \"SE\", \n   \"figi_ticker\": \"ABT:SE\", \n   \"figi_uniqueid\": \"EQ0010000200022000\", \n   \"last_crsp_adj_date\": \"2017-10-05\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XSWX\", \n   \"primary_listing\": false, \n   \"security_name\": \"ABBOTT LABORATORIES\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5N9M6\", \n   \"stock_exchange\": \"SIX\", \n   \"ticker\": \"ABT\"\n  }, \n  {\n   \"composite_figi\": \"BBG000BN5WF4\", \n   \"composite_figi_ticker\": \"ABT:SW\", \n   \"currency\": \"CHF\", \n   \"delisted_security\": true, \n   \"etf\": false, \n   \"exch_symbol\": \"^XBRN\", \n   \"figi\": \"BBG006M6Y1D4\", \n   \"figi_exch_cntry\": \"BW\", \n   \"figi_ticker\": \"ABT:BW\", \n   \"figi_uniqueid\": \"EQ0010000200022000\", \n   \"last_crsp_adj_date\": null, \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XBRN\", \n   \"primary_listing\": false, \n   \"security_name\": \"ABBOTT LABORATORIES\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5N9M6\", \n   \"stock_exchange\": \"BRN\", \n   \"ticker\": \"US0028241000\"\n  }, \n  {\n   \"composite_figi\": \"BBG000H2RD53\", \n   \"composite_figi_ticker\": \"ABL:GR\", \n   \"currency\": \"EUR\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XHAM\", \n   \"figi\": \"BBG000H2SNT4\", \n   \"figi_exch_cntry\": \"GH\", \n   \"figi_ticker\": \"ABL:GH\", \n   \"figi_uniqueid\": \"EQ0010000200001003\", \n   \"last_crsp_adj_date\": \"2017-07-12\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XHAM\", \n   \"primary_listing\": false, \n   \"security_name\": \"ABBOTT LABORATORIES\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5N9M6\", \n   \"stock_exchange\": \"HAM\", \n   \"ticker\": \"ABL\"\n  }, \n  {\n   \"composite_figi\": \"BBG004BWL442\", \n   \"composite_figi_ticker\": \"ABT:CI\", \n   \"currency\": \"USD\", \n   \"delisted_security\": true, \n   \"etf\": false, \n   \"exch_symbol\": \"^XSGO\", \n   \"figi\": \"BBG004BWL442\", \n   \"figi_exch_cntry\": \"CI\", \n   \"figi_ticker\": \"ABT:CI\", \n   \"figi_uniqueid\": \"EQ0000000029266263\", \n   \"last_crsp_adj_date\": \"2017-07-06\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XSGO\", \n   \"primary_listing\": false, \n   \"security_name\": \"ABBOTT LABORATORIES\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5N9M6\", \n   \"stock_exchange\": \"SGO\", \n   \"ticker\": \"ABT\"\n  }, \n  {\n   \"composite_figi\": \"BBG000H2RD53\", \n   \"composite_figi_ticker\": \"ABL:GR\", \n   \"currency\": \"EUR\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XMUN\", \n   \"figi\": \"BBG000H2SJW9\", \n   \"figi_exch_cntry\": \"GM\", \n   \"figi_ticker\": \"ABL:GM\", \n   \"figi_uniqueid\": \"EQ0010000200001003\", \n   \"last_crsp_adj_date\": \"2017-10-12\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XMUN\", \n   \"primary_listing\": false, \n   \"security_name\": \"ABBOTT LABORATORIES\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5N9M6\", \n   \"stock_exchange\": \"MUN\", \n   \"ticker\": \"ABL\"\n  }, \n  {\n   \"composite_figi\": \"BBG000H2RD53\", \n   \"composite_figi_ticker\": \"ABL:GR\", \n   \"currency\": \"EUR\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XSTU\", \n   \"figi\": \"BBG000H2SJ04\", \n   \"figi_exch_cntry\": \"GS\", \n   \"figi_ticker\": \"ABL:GS\", \n   \"figi_uniqueid\": \"EQ0010000200001003\", \n   \"last_crsp_adj_date\": \"2017-10-12\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XSTU\", \n   \"primary_listing\": false, \n   \"security_name\": \"ABBOTT LABORATORIES\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5N9M6\", \n   \"stock_exchange\": \"STU\", \n   \"ticker\": \"ABL\"\n  }, \n  {\n   \"composite_figi\": \"BBG001KWXLR2\", \n   \"composite_figi_ticker\": \"ABTCHF:EU\", \n   \"currency\": \"CHF\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XLON\", \n   \"figi\": \"BBG001KWXLS1\", \n   \"figi_exch_cntry\": \"EU\", \n   \"figi_ticker\": \"ABTCHF:EU\", \n   \"figi_uniqueid\": \"EQ0000000017005541\", \n   \"last_crsp_adj_date\": \"2016-10-12\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XLON\", \n   \"primary_listing\": false, \n   \"security_name\": \"ABBOTT LABORATORIES\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5N9M6\", \n   \"stock_exchange\": \"LSE\", \n   \"ticker\": \"0Q15\"\n  }, \n  {\n   \"composite_figi\": null, \n   \"composite_figi_ticker\": null, \n   \"currency\": \"SEK\", \n   \"delisted_security\": true, \n   \"etf\": false, \n   \"exch_symbol\": \"^XSTO\", \n   \"figi\": null, \n   \"figi_exch_cntry\": null, \n   \"figi_ticker\": null, \n   \"figi_uniqueid\": null, \n   \"last_crsp_adj_date\": null, \n   \"market_sector\": null, \n   \"mic\": \"XSTO\", \n   \"primary_listing\": false, \n   \"security_name\": \"ABBOTT LABORATORIES\", \n   \"security_type\": \"Ordinary Shares\", \n   \"share_class_figi\": null, \n   \"stock_exchange\": \"STO\", \n   \"ticker\": \"E-US0028241000\"\n  }, \n  {\n   \"composite_figi\": \"BBG000H2RD53\", \n   \"composite_figi_ticker\": \"ABL:GR\", \n   \"currency\": \"EUR\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XETR\", \n   \"figi\": \"BBG000H2RGK9\", \n   \"figi_exch_cntry\": \"GY\", \n   \"figi_ticker\": \"ABL:GY\", \n   \"figi_uniqueid\": \"EQ0010000200001003\", \n   \"last_crsp_adj_date\": \"2017-10-12\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XETR\", \n   \"primary_listing\": false, \n   \"security_name\": \"ABBOTT LABORATORIES\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5N9M6\", \n   \"stock_exchange\": \"XETRA\", \n   \"ticker\": \"ABL\"\n  }, \n  {\n   \"composite_figi\": \"BBG000L47866\", \n   \"composite_figi_ticker\": \"ABT*:MM\", \n   \"currency\": \"MXN\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XMEX\", \n   \"figi\": \"BBG000L478Y5\", \n   \"figi_exch_cntry\": \"MM\", \n   \"figi_ticker\": \"ABT*:MM\", \n   \"figi_uniqueid\": \"EQ0000000001393198\", \n   \"last_crsp_adj_date\": \"2017-10-12\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XMEX\", \n   \"primary_listing\": false, \n   \"security_name\": \"ABBOTT LABORATORIES\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5N9M6\", \n   \"stock_exchange\": \"MEX\", \n   \"ticker\": \"ABT\"\n  }, \n  {\n   \"composite_figi\": \"BBG000H2RD53\", \n   \"composite_figi_ticker\": \"ABL:GR\", \n   \"currency\": \"EUR\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XFRA\", \n   \"figi\": \"BBG000H2RDP1\", \n   \"figi_exch_cntry\": \"GF\", \n   \"figi_ticker\": \"ABL:GF\", \n   \"figi_uniqueid\": \"EQ0010000200001003\", \n   \"last_crsp_adj_date\": \"2017-10-12\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XFRA\", \n   \"primary_listing\": false, \n   \"security_name\": \"ABBOTT LABORATORIES\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5N9M6\", \n   \"stock_exchange\": \"FRA\", \n   \"ticker\": \"ABL\"\n  }, \n  {\n   \"composite_figi\": \"BBG000H2RD53\", \n   \"composite_figi_ticker\": \"ABL:GR\", \n   \"currency\": \"EUR\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XDUS\", \n   \"figi\": \"BBG000H2RFM9\", \n   \"figi_exch_cntry\": \"GD\", \n   \"figi_ticker\": \"ABL:GD\", \n   \"figi_uniqueid\": \"EQ0010000200001003\", \n   \"last_crsp_adj_date\": \"2017-07-12\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XDUS\", \n   \"primary_listing\": false, \n   \"security_name\": \"ABBOTT LABORATORIES\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5N9M6\", \n   \"stock_exchange\": \"DUS\", \n   \"ticker\": \"ABL\"\n  }, \n  {\n   \"composite_figi\": \"BBG000H2RD53\", \n   \"composite_figi_ticker\": \"ABL:GR\", \n   \"currency\": \"EUR\", \n   \"delisted_security\": false, \n   \"etf\": false, \n   \"exch_symbol\": \"^XBER\", \n   \"figi\": \"BBG000H2SL90\", \n   \"figi_exch_cntry\": \"GB\", \n   \"figi_ticker\": \"ABL:GB\", \n   \"figi_uniqueid\": \"EQ0010000200001003\", \n   \"last_crsp_adj_date\": \"2017-10-12\", \n   \"market_sector\": \"Equity\", \n   \"mic\": \"XBER\", \n   \"primary_listing\": false, \n   \"security_name\": \"ABBOTT LABORATORIES\", \n   \"security_type\": \"Common Stock\", \n   \"share_class_figi\": \"BBG001S5N9M6\", \n   \"stock_exchange\": \"BER\", \n   \"ticker\": \"ABL\"\n  }\n ], \n \"short_description\": \"Abbott Laboratories engages in the discovery, development, manufacture and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Vascular Products. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure and other medical device products. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.\", \n \"sic\": 2834, \n \"standardized_active\": true, \n \"stock_exchange\": \"NYSE\", \n \"template\": \"industrial\", \n \"ticker\": \"ABT\"\n}"